Literature DB >> 8538067

Effect of UF-021 on optic nerve head circulation in rabbits.

T Sugiyama1, I Azuma.   

Abstract

The effect of UF-021, a prostaglandin-related compound which has recently become available for treatment as an antiglaucoma agent, on the circulation of the optic nerve head (ONH) was studied in normal rabbit eyes and in eyes with circulation insufficiency induced by endothelin-1 (ET-1). The capillary blood flow in the ONH was measured for 5 hours using a hydrogen gas clearance flowmeter, and the intraocular pressure (IOP) was also measured. A single instillation of UF-021 reduced the IOP (maximum reduction: 3.7 mmHg at 2 hours) but had no effect on ONH blood flow in normal rabbit eyes. Intravitreal injection of UF-021 reduced IOP to a lesser extent (maximum reduction: 1.8 mmHg at 3.5 hours) and significantly increased ONH blood flow from 1 to 3.5 hours (maximum increment: 14% of the initial value at 1 hour). Pretreatment with intravitreal injection of UF-021 did not affect IOP but partly inhibited the ONH blood-flow-decreasing effect of ET-1. These results suggest that UF-021 can improve ONH probably by reducing the resistance in ONH blood vessels.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8538067

Source DB:  PubMed          Journal:  Jpn J Ophthalmol        ISSN: 0021-5155            Impact factor:   2.447


  9 in total

1.  Effect of topical unoprostone isopropyl on optic nerve head circulation in controls and in normal-tension glaucoma patients.

Authors:  Itaru Kimura; Kei Shinoda; Tomihiko Tanino; Yuichiro Ohtake; Yukihiko Mashima
Journal:  Jpn J Ophthalmol       Date:  2005 Jul-Aug       Impact factor: 2.447

Review 2.  Effects of antiglaucoma drugs on blood flow of optic nerve heads and related structures.

Authors:  Chihiro Mayama; Makoto Araie
Journal:  Jpn J Ophthalmol       Date:  2013-01-16       Impact factor: 2.447

Review 3.  Endothelin antagonism as an active principle for glaucoma therapy.

Authors:  Rita Rosenthal; Michael Fromm
Journal:  Br J Pharmacol       Date:  2011-02       Impact factor: 8.739

4.  Unoprostone (isopropyl unoprostone)

Authors:  M Haria; C M Spencer
Journal:  Drugs Aging       Date:  1996-09       Impact factor: 3.923

5.  Unoprostone as adjunctive therapy to timolol: a double masked randomised study versus brimonidine and dorzolamide.

Authors:  A Hommer; B Kapik; N Shams
Journal:  Br J Ophthalmol       Date:  2003-05       Impact factor: 4.638

6.  The relationship between choroidal blood flow and glaucoma progression in a Japanese study population.

Authors:  Naoki Kiyota; Yukihiro Shiga; Kazuko Omodaka; Toru Nakazawa
Journal:  Jpn J Ophthalmol       Date:  2022-07-05       Impact factor: 2.211

7.  Visual prognosis better in eyes with less severe reduction of visual acuity one year after onset of Leber hereditary optic neuropathy caused by the 11,778 mutation.

Authors:  Yukihiko Mashima; Kazuteru Kigasawa; Kei Shinoda; Masato Wakakura; Yoshihisa Oguchi
Journal:  BMC Ophthalmol       Date:  2017-10-18       Impact factor: 2.209

Review 8.  Safety of unoprostone isopropyl as mono- or adjunctive therapy in patients with primary open-angle glaucoma or ocular hypertension.

Authors:  Paulo Augusto de Arruda Mello; Natalia C Yannoulis; Reza M Haque
Journal:  Drug Saf       Date:  2002       Impact factor: 5.228

9.  Intraocular pressure and visual field changes in normal-tension glaucoma patients treated using either unoprostone or latanoprost: a prospective comparative study.

Authors:  Daisuke Takemoto; Tomomi Higashide; Yoshiaki Saito; Shinji Ohkubo; Sachiko Udagawa; Hisashi Takeda; Kazuhisa Sugiyama
Journal:  Clin Ophthalmol       Date:  2017-09-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.